Researchers at the duke university medical center are conducting a program of research to evaluate the efficacy of autologous and allogeneic cord blood for improving outcomes of individuals with autism spectrum disorder.
Stem cell autism duke.
Results from a phase i trial were published april 5 in the journal stem cells translational medicine.
However it is illegal in the u s.
Joanne kurtzberg is an internationally renowned expert in pediatric hematology oncology pediatric blood and marrow transplantation umbilical cord blood banking and transplantation and novel applications of cord blood in the emerging fields of cellular therapies and regenerative medicine.
In response to rising demand from parents for unproven stem cell therapies kurtzberg who is a cord blood pioneer launched the trial together with geraldine dawson director of duke university s center for autism and brain development with funding from the marcus foundation.
Results from a phase i trial were published april 5 in the journal stem cells translational medicine.
Food and drug administration has approved the use of stem cells for blood disorders including cancer but not for autism.
Mscs are building block cells that not only can self replicate but can also differentiate into many different cell types.
Kurtzberg pioneered the use of umbilical cord blood as an alternative stem cell.
The treatments must use stem cells from umbilical cord blood or bone marrow.
Duke autism center of excellence establishes community engagement advisory board september 17 2020 learn more.
Center announces the 2020 2021 autism speaker series october 7 2020 4 00pm.
Gracie gregory made a dramatic improvement after participating in an initial stem cell trial at duke.
The duke university study included 25 children ages 2 6 with autism and assessed whether a transfusion of the youngsters own umbilical cord blood containing rare stem cells would help treat.
Although additional research is needed scientists at duke health are reporting results from a small early stage study of an experimental autism therapy for children using their own umbilical cord blood.
Although additional research is needed scientists at duke health are reporting results from a small early stage study of an experimental autism therapy for children using their own umbilical cord blood.